Delivery Order SPE2DB20D3101-SPE2DB25FRAY2
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,429.76 and covers the procurement of CATHFLO ACTIVASE 2 MG VIALS, a medical supply item. The contract is a firm fixed-price delivery order with a completion date of March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $24,379.93 and is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a critical medical commodity. The contract is a Firm Fixed Price type and has an ultimate completion date of May 15, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,131.20, is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 8, 2025. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a ceiling value of $2,076.90 and a completion date of March 19, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $2,246.16 firm fixed-price contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a medical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,378.48 firm fixed-price contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a performance period ending on May 21, 2024. The award is not associated with a set-aside. Amerisourcebergen holds a large Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,317.92, is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product. This is a firm fixed-price delivery order contract with an ultimate completion date of December 27, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,688.31, is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product, to support federal healthcare programs. The contract is a firm fixed-price, delivery order type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,188.23 firm fixed-price delivery order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a medical product. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,565,778,830 units of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $9,654.84 and a period of performance through September 13, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide critical...